TCL1A Antikörper (AA 2-109)
Kurzübersicht für TCL1A Antikörper (AA 2-109) (ABIN7871766)
Target
Alle TCL1A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- AA 2-109
-
Verwendungszweck
- TCL1 Antibody (azide and preservative free)
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- A portion of amino acids 2-109 from the human protein was used as the immunogen for the TCL1 antibody.
-
Isotyp
- IgG2a, kappa
-
-
-
-
Applikationshinweise
-
Optimal dilution of the TCL1 antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the TCL1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- TCL1A (T-Cell Leukemia/lymphoma 1A (TCL1A))
-
Andere Bezeichnung
- TCL1
-
Hintergrund
- T-cell leukemia/Lymphoma Protein 1A (TCL-1A), also known as p14TCL1 is a product of the TCL1 gene that is involved in T-cell prolymphocytic leukemia (TPLL). T-PLL is a rare form of mature T-cell leukemia, which is consistently associated with chromosomal rearrangements characterized by the juxtaposition of the TCRA locus on chromosome 14q11 and the TCL1A gene on 14q32.13. TCL1 is overexpressed in Burkitt lymphoma, the majority of AIDS-related non-Hodgkin lymphoma-designated immunoblastic plasmacytoid lymphoma, lymphoblastic lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, diffuse large B-cell lymphoma, and primary cutaneous B-cell lymphoma.
-
UniProt
- P56279
-
Pathways
- Stem Cell Maintenance
Target
-